Miyamoto K - Search Results

1

Insulin signaling in adipocytes differentiated from mouse stromal MC3T3-G2/PA6 cells.

Morito S, Yaguchi K, Imada M, Tachikawa C, Nomura M, Moritani S, Igarashi M, Yokogawa K, Miyamoto K. Morito S, et al. Among authors: miyamoto k. Biol Pharm Bull. 2005 Nov;28(11):2040-5. doi: 10.1248/bpb.28.2040. Biol Pharm Bull. 2005. PMID: 16272686 Free article.

2

Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells.

Nomura M, Takahashi T, Nagata N, Tsutsumi K, Kobayashi S, Akiba T, Yokogawa K, Moritani S, Miyamoto K. Nomura M, et al. Among authors: miyamoto k. Biol Pharm Bull. 2008 Jul;31(7):1403-9. doi: 10.1248/bpb.31.1403. Biol Pharm Bull. 2008. PMID: 18591783 Free article.

3

Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2.

Yamagami H, Nishioka T, Ochiai E, Fukushima K, Nomura M, Kasugai S, Moritani S, Yokogawa K, Miyamoto K. Yamagami H, et al. Among authors: miyamoto k. Biochem Pharmacol. 2003 Sep 1;66(5):801-7. doi: 10.1016/s0006-2952(03)00409-x. Biochem Pharmacol. 2003. PMID: 12948861

4

Inhibitory mechanism of caffeine on insulin-stimulated glucose uptake in adipose cells.

Akiba T, Yaguchi K, Tsutsumi K, Nishioka T, Koyama I, Nomura M, Yokogawa K, Moritani S, Miyamoto K. Akiba T, et al. Among authors: miyamoto k. Biochem Pharmacol. 2004 Nov 15;68(10):1929-37. doi: 10.1016/j.bcp.2004.07.036. Biochem Pharmacol. 2004. PMID: 15476664

5

Inhibition of epidermal growth factor-induced cell transformation and Akt activation by caffeine.

Nomura M, Ichimatsu D, Moritani S, Koyama I, Dong Z, Yokogawa K, Miyamoto K. Nomura M, et al. Among authors: miyamoto k. Mol Carcinog. 2005 Sep;44(1):67-76. doi: 10.1002/mc.20120. Mol Carcinog. 2005. PMID: 16044420 Free article.

6

Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.

Wang FP, Wang L, Yang JS, Nomura M, Miyamoto K. Wang FP, et al. Among authors: miyamoto k. Biol Pharm Bull. 2005 Oct;28(10):1979-82. doi: 10.1248/bpb.28.1979. Biol Pharm Bull. 2005. PMID: 16204959 Free article.

7

Effects of 1-benzylxanthines on cyclic AMP phosphodiesterase 4 isoenzyme.

Suzuki H, Sawanishi H, Nomura M, Shimada T, Miyamoto K. Suzuki H, et al. Among authors: miyamoto k. Biol Pharm Bull. 2006 Jan;29(1):131-4. doi: 10.1248/bpb.29.131. Biol Pharm Bull. 2006. PMID: 16394525 Free article.

8

Serum aminotransferase activity as a predictor for estimation of total clearance of hepatically metabolized drugs in rats with acute hepatic failure.

Yokogawa K, Ido A, Kurihara T, Mano Y, Nomura M, Ishizaki J, Miyamoto K. Yokogawa K, et al. Among authors: miyamoto k. Biol Pharm Bull. 2006 Jan;29(1):141-5. doi: 10.1248/bpb.29.141. Biol Pharm Bull. 2006. PMID: 16394527 Free article.

9

Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol.

Yokogawa K, Toshima K, Yamoto K, Nishioka T, Sakura N, Miyamoto K. Yokogawa K, et al. Among authors: miyamoto k. Biol Pharm Bull. 2006 Jun;29(6):1229-33. doi: 10.1248/bpb.29.1229. Biol Pharm Bull. 2006. PMID: 16755022 Free article.

10

Development of dosage design of hepatic metabolizing drugs using serum albumin level in chronic hepatic failure.

Mano Y, Tsukada H, Kurihara T, Nomura M, Yokogawa K, Miyamoto K. Mano Y, et al. Among authors: miyamoto k. Biol Pharm Bull. 2006 Aug;29(8):1692-9. doi: 10.1248/bpb.29.1692. Biol Pharm Bull. 2006. PMID: 16880627 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,551 results

Search Page

Filters